ME/CFS Adaptive Therapeutic Solution Platform (MEDUSA) – Phase 1
The purpose of phase 1 of this study is to identify promising treatments for specific subgroups of people with ME/CFS, which will be evaluated in later phases.
at the CHU Sainte-Justine/
Université de Montréal
The ME / CFS Collaborative Research Center, established in 2020 at CHU Sainte-Justine /Université de Montréal, increases OMF’s international collaborative efforts through the End ME/CFS Project. Directed by Alain Moreau, PhD, the Quebec, Canada-based laboratory has been researching ME / CFS for several years.
Latest Video
Alain Moreau, PhD, is a Full Professor in the Department of Stomatology, Faculty of Dentistry and Department of Biochemistry and Molecular Medicine, Faculty of Medicine, at Université de Montréal, Montréal, Québec, Canada. Additionally, Dr. Moreau is the Director of Network for Canadian Oral Health Research. He is the Scientific Director of the Viscogliosi Laboratory in Molecular Genetics of Musculoskeletal Diseases, Sainte-Justine University Research Center, Montréal, Québec.
Dr. Moreau’s chief interests of study are pediatric scoliosis, osteoarthritis, osteoporosis, and Myalgic Encephalomyelitis. Dr. Moreau is a member of the Open Medicine Foundation Scientific Advisory Board and is the Director of the Interdisciplinary Canadian Collaborative Myalgic Encephalomyelitis Research Network, a national research network funded by the Canadian Institute of Health Research.
The purpose of phase 1 of this study is to identify promising treatments for specific subgroups of people with ME/CFS, which will be evaluated in later phases.
The purpose of this study is to facilitate early detection of ME/CFS in people with Long COVID and better understand disease progression.
The overarching goal of RASPBERRY-ME project is the characterization of the biomolecular signature of Myalgic Encephalomyelitis using Label-free Raman Spectroscopy (RS) and machine learning models.
The REMEDIAL project continues the work commenced with MAESTRO and will lead to a better understanding of the molecular mechanisms underlying ME/CFS pathophysiology,
the persistence and variability of the symptoms, and will contribute to the identification of targets and therapeutic agents for intervention.
Decode the molecular mechanisms underlying ME/CFS and contributing to specific symptoms with a particular emphasis of post-exertional malaise (PEM). This includes deep phenotyping of ME patients and global proteomic/metabolomics plasma profiling of ME..
CHU Sainte-Justine Research Center
Université de Montréal
Alain Moreau, PhD , Scientific Director
Anita Franco, MSc, Lab coordinator
Dashen Wang, MD, PhD, Research Associate
Mohamed Elbakry, PhD , Research Associate
Viorica Lascau, MSc , Research coordinator – certification manager
Sophie Perreault, RN , Clinical research nurse
Valerie Tremblay, RN, Clinical research nurse
Hélène Gagnon, RN, Clinical research nurse
Iurie Caraus, PhD , Postdoctoral fellow
Wesam Elremaly, PhD, Postdoctoral fellow
Lynda Chalder, MSc, PhD student
Evguenia Nepotchatykh, BSc, PhD student
Atefeh Moezzi, MSc, PhD student
Corinne Leveau, BSc, MSc student
Bita Rostami, BSc, MSc student
Marie-Yvonne Akoume PhD, Invited professor – ICanCME Research Network Investigator
Valérie Marcil PhD, Associate Professor – ICanCME Research Network Investigator
Emile Levy, MD, PhD ,Full Professor – ICanCME Research Network Investigator
University of Florida Atlantic
Dawei Li, PhD, Associated Professor – ICanCME Research Network Investigator
Jason Kost BSc , Research Assistant – ICanCME Research Network Member
Please help us expand our research efforts across the globe. Every donation brings us closer to a fully-funded research effort and the answers we all seek.